Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 3Phase NA 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Sarcoma 2Other hematologic neoplasm 2Plasma cell 1

Conditions

Hodgkin Disease 24Lymphoma 18Testicular Neoplasms 4Teratoma 3Recurrence 3Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3HIV Infections 3Vulvar Neoplasms 2Testicular Germ Cell Tumor 2Seminoma 2Neoplasms, Germ Cell and Embryonal 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Head and Neck Neoplasms 2Endodermal Sinus Tumor 2Dendritic Cell Sarcoma, Interdigitating 2Carcinoma, Embryonal 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Ulcer 1Squamous Cell Carcinoma of Head and Neck 1Sertoli-Leydig Cell Tumor 1Sarcoma, Kaposi 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Processes 1Ovarian gynandroblastoma 1

Interventions

Rituximab 208Cyclophosphamide 167Etoposide 83Prednisone 79Vincristine 77Doxorubicin 76Peripheral Blood Stem Cell Transplantation 61Filgrastim 55Cytarabine 47fludarabine phosphate 46Radiotherapy 43Lenalidomide 41Mycophenolic Acid 40Tacrolimus 36Methotrexate 35Melphalan 35Busulfan 35Gemcitabine 32Carmustine 32Cyclosporine 31Whole-Body Irradiation 29Ifosfamide 28Antilymphocyte Serum 26zanubrutinib 25polatuzumab vedotin 25Dexamethasone 23Methylprednisolone 22ibritumomab tiuxetan 20Carboplatin 20Oxaliplatin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Large B-Cell, Diffuse × Bleomycin × Clear all
NCT00983944 2017-11-30

Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Withdrawn
LymphoidSarcoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT00002657 2013-01-24

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

SWOG Cancer Research Network

Phase 2 Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

NCT00003110 2010-06-11

Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma

Case Comprehensive Cancer Center

Phase 2 Completed
5 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡